Tuesday broker round-up - UPDATE

13th Mar 2012 09:59

AstraZeneca: Panmure Gordon keeps buy rating and 3,600p target.Bellway: Credit Suisse maintains outperform rating.BG Group: Nomura raises target from 1,865p to 1,950p, buy rating kept.Computacenter: Panmure Gordon ups target from 490p to 501p, buy rating unchanged.Hays: Credit Suisse ups target from 80p to 96p, outperform rating kept.Inchcape: Panmure Gordon reiterates hold recommendation and 372p target; Numis downgrades from buy to hold, target left at 390p.Inmarsat: Citi downgrades from neutral to sell, target cut from 480p to 410p.Interserve: UBS ups target from 225p to 260p, sell rating unchanged.JD Wetherspoon: UBS cuts target from 460p to 440p, buy rating unchanged.Lloyds: WestLB downgrades from buy to add, target cut from 42p to 41p.Meggitt: Credit Suisse reiterates underperform rating and 330p target.Persimmon: Credit Suisse maintains outperform rating.Premier Farnell: Shore Capital upgrades from sell to hold.Premier Foods: Panmure Gordon hikes target from 2p to 6p, but maintains sell rating.Royal Bank of Scotland: Credit Suisse reiterates neutral and 22p target.Sage Group: Goldman Sachs upgrades from sell to neutral, target raised from 330p to 345p.Schroders: Credit Suisse downgrades from neutral to underperform, target lifted from 1,390p to 1,550p.Smiths Group: Credit Suisse reiterates outperform rating and 1,200p target.Standard Life: Panmure Gordon downgrades from buy to hold, target left at 240p.SThree: Credit Suisse raises target from 270p to 345p, outperform rating kept.Taylor Wimpey: Credit Suisse maintains outperform rating.UNITE Group: Bank of America Merrill Lynch upgrades from neutral to buy, target lifted from 175p to 240p.